早产儿视网膜病变婴儿泪液代谢组学特征改变
一项前瞻性研究纳入47名早产儿共94只眼,采用超高效液相色谱-质谱联用进行非靶向泪液代谢组学分析,发现ROP患儿泪液中3,5-二叔丁基-4-羟基苯甲醛、咖啡因和海藻糖上调,尿酸、二高-γ-亚麻酸等9种代谢物下调,其中6-酮-前列腺素F1α分类早产儿有无ROP的AUC为0.893。
要点
- ROP患儿泪液代谢物谱发生改变,涉及维生素B6、嘌呤、咖啡因、精氨酸及淀粉和蔗糖代谢通路。
- 6-酮-前列腺素F1α分类有无ROP的AUC为0.893(范围0.800-0.986,P<0.001)。
- 部分失调代谢物表达水平与经后年龄、胎龄、出生体重和ROP严重程度存在不同程度相关。
核心结论
- ROP中失调的泪液代谢物丰度与疾病严重程度相关,可能作为无创生物标志物,有潜力作为补充筛查工具。
研究设计与样本
- 前瞻性研究,纳入47名早产儿共94只眼,其中ROP组23名婴儿(15名需治疗ROP,8名不需治疗ROP),无ROP组24名婴儿。
- 在表面麻醉后用Schirmer试纸采集泪液样本,散瞳后行详细眼底检查,记录人口学和出生史数据。
- 基于超高效液相色谱-质谱联用进行非靶向泪液代谢组学分析。
主要发现
- 经性别、经后年龄、胎龄和出生体重校正后,在定量的145种代谢物中,ROP患儿泪液中3,5-二叔丁基-4-羟基苯甲醛、咖啡因和海藻糖较无ROP早产儿上调,尿酸、二高-γ-亚麻酸、诺卡酮、吡哆醛、鸟氨酸、6-酮-前列腺素F1α、腺苷和四氢皮质醇下调(所有校正错误发现率[FDR adj] < 0.05)。
- 在需治疗ROP亚组和不需治疗ROP亚组中分别进一步发现9种和1种失调代谢物。
- 部分失调代谢物表达水平与经后年龄、胎龄、出生体重和ROP严重程度存在不同程度相关。
- 失调泪液代谢物主要与维生素B6、嘌呤、咖啡因、精氨酸及淀粉和蔗糖代谢通路相关。
- 6-酮-前列腺素F1α在分类有无ROP的早产儿中表现最佳,曲线下面积(AUC)为0.893(范围=0.800-0.986),P < 0.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to investigate the characteristics of metabolomic profile in the tears from infants with retinopathy of prematurity (ROP) and further define noninvasive biomarkers. METHODS: This prospective study included 94 eyes from 47 premature infants. Tear samples from 23 infants with ROP (15 treatment-requiring ones [ROP (t)] and 8 non-treatment-requiring ones [ROP (nt)]) and 24 infants without ROP were collected with Schirmer strips after topical anesthesia. Detailed fundus examination upon pupil dilation were conducted, with data on demographics and birth history recorded. Untargeted tear metabolomic analysis based on ultra-performance liquid chromatography-mass spectrometry was performed. RESULTS: Adjusted by sex, postmenstrual age, gestational age, and birth weight, among 145 metabolites quantified, 3,5-di-tert-butyl-4-hydroxybenzaldehyde, caffeine, and trehalose were identified to be upregulated in the tears from infants with ROP when compared to those from premature infants with non-ROP, whereas uric acid, dihomo-γ-linolenic acid, nootkatone, pyridoxal, ornithine, 6-keto-prostaglandin F1 alpha, adenosine, and tetrahydrocortisol were downregulated (all adjusted false discovery rate [FDR adj] < 0.05). Nine and one dysregulated metabolites were further found in the ROP (t) and ROP (nt) subgroups, respectively. Some of these metabolites exhibited expression levels correlated with postmenstrual age, gestational age, birth weight, and ROP severity in varying degrees. The dysregulated tear metabolites were fundamentally related to vitamin B6, purine, caffeine, arginine, and starch and sucrose metabolism pathways. The 6-keto-prostaglandin F1 alpha obtained the best performance in classifying premature infants with and without ROP (area under the curve [AUC] of 0.893 [range = 0.800-0.986], P < 0.001). CONCLUSIONS: Dysregulated tear metabolites in ROP exhibited abundance correlated with severity of the disease and might be noninvasive biomarkers that potentially serve as complementary screening tools.
引用
- Fan Z, Yang S, Lu X, et al. Alteration of Tear Metabolomics Profiling in Infants With Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2025. PMID: 40540260. doi:10.1167/iovs.66.6.61
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。